Description
Data Bridge Market Research analyzes that the Middle East molecular point of care testing (using NAAT) market will grow at a CAGR of 7.4% from 2021 to 2028. Middle East molecular point of care testing (using NAAT) market is expected to grow due to improving healthcare facilities and infrastructures and the adoption of end-of-care testing at the hospital, laboratories, and clinics, which can drive the development of the market. The other factors anticipated to propel the growth of the molecular point of care testing (using NAAT) market include the rising prevalence of infectious diseases. Other factors, such as the lack of skilled professionals and the high cost of customized molecular point of care testing (using NAAT), hamper the growth of the market of the Middle East molecular point of care testing (using NAAT). On the other hand, the increased healthcare expenditure and emerging countries with developed hospitals act as an opportunity to grow the Middle East molecular point of care testing (using NAAT) market.
Sample Report: https://www.databridgeMarket research.com/request-a-sample/?dbmr=middle-east-molecular-point-of-care-testing-using-naat-Market
Market Analysis and Insights: Middle East Molecular Point of Care Testing (Using NAAT) Market
POCT is characterized as testing which can be done close to the patient where a medical decision can be made immediately, including the results and monitoring. POCT devices now entering clinical use are based on nucleic acid amplification technologies (NAAT), defined here as second-generation devices. These platforms generally have improved sensitivity, typically 60 to 90%, compared to first-generation POCTs, and require portable instrumentation with a footprint of approximately 30cm x 30cm. These instruments are essentially used in molecularly detecting various disorders such as HIV, HPV, and respiratory disease through NAAT technology. NAAT is Nucleic Acid Amplification Techniques that allow the identification of pathogenic organisms by detecting their DNA or RNA. In the worldwide pandemic, attempt to synergize the sensitivity of NAATs and the ease of use of POCT assays, miniaturized NAAT-based POCT devices and assays were devised for faster screening and diagnosis of COVID-19, which also propelled the growth of the market.
Access Full Report:- https://www.databridgemarketresearch.com/reports/middle-east-molecular-point-of-care-testing-using-naat-market
- INCREASE IN PREVALENCE OF CHRONIC DISEASES
It is a common fact that health degeneration starts with an increase in age. As the rate of chronic disease grows with time, the factors associated with the disease rates also increase. The high number of obese/ overweight population also has increased the prevalence of chronic diseases in various regions across the globe. The rise in the number of chronic diseases similar to HPV, STI, and TB, among more, has led to people opting for NAAT-based point-of-care and products for testing. Therefore, this will drive the growth of the Middle East molecular point of care testing (using NAAT) market in the coming years.
- IMPROVEMENT IN DIAGNOSIS-SEEKING RATE
With the increase in the successful diagnosis of chronic diseases, including cancer, anemia, type 2 diabetes, and others, the improved health care professionals provide regular training sessions for the professionals for conducting tests in account for the improvement of diagnosis rate in the region. With the increase in the burden of diseases, the diagnosis rate is also increasing. With the advancements in the diagnosis, the rate is also growing for people going through the diagnosis.
Middle East Molecular Point Of Care Testing (Using NAAT) Market Scope and Market Size
The Middle East molecular point of care testing (using NAAT) market is categorized into five notable segments based on the product, indication, end user, mode of testing, and distribution channel. The growth amongst these segments will help to analyze market growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
· On the basis of indication, the Middle East molecular point of care testing (using NAAT) Market is segmented into sexually transmitted infection (STI) testing, respiratory infection testing, gastrointestinal tract infection testing, and others. In 2021, the respiratory segment in the molecular point of care testing (using NAAT) Market is expected to dominate because of a sudden outbreak of COVID-19 and a rise in the incidence of various other respiratory disorders due to the no-contact spread of the disease.
· On the basis of product, the Middle East molecular point of care testing (using NAAT) Market is segmented into instruments, consumables and reagents. In 2021, the consumables & reagents segment in the molecular point of care testing (using NAAT) Market is expected to grow due to the increasing demand for the product of molecular POCT in this region.
· On the basis of end user, the Middle East molecular point of care testing (using NAAT) Market is segmented into laboratories, hospitals, clinics, ambulatory centers, home care, assisted living facilities, and others. In 2021, the laboratories segment is expected to dominate the Market because the major laboratories around the world are expanding their research and medical laboratories to upgrade the medical facilities.
· On the basis of mode of testing, the Middle East molecular point of care testing (using NAAT) Market is segmented into prescription-based testing and OTC testing. In 2021, the prescription-based testing segment in the molecular point of care testing (using NAAT) Market is expected to grow because the use of NAAT in PCOT is new and thus requires expert advice and monitoring, which increase the Market for prescription-based testing.
· On the basis of distribution channel, the Middle East molecular point of care testing (using NAAT) Market is segmented into direct tender, third party distributor, online sales. In 2021, the direct sales segment in the molecular point of care testing (using NAAT) Market is expected to grow due to the increased demand for advanced technologies and testing requirements in medical care for operations and diagnosis.
Get TOC of the Report: https://www.databridgeMarket research.com/toc/?dbmr=middle-east-molecular-point-of-care-testing-using-naat-Market
Major TOC of the Middle East Molecular Point of Care Testing (Using NAAT) Market Report
Chapter One:
MARKET SEGEMENTATION
EXECUTIVE SUMMARY
PREMIUM INSIGHTS
MARKET OVERVIEW
Middle East Molecular Point of Care Testing (Using NAAT) Market Country Level Analysis
The market is analyzed in the Middle East molecular point of care testing (using NAAT). Market size insights and trends are provided based on product, indication, end user, mode of testing, and distribution channel.
Middle East molecular point of care testing (using NAAT) market report covers Saudi Arabia, U.A.E, Israel, Egypt, and the rest of Middle East.
Saudi Arabia dominates the Middle East molecular point of care testing (using NAAT) market with a CAGR of around 9.2% in terms of market share and market revenue. It will continue to flourish its dominance during the forecast period. This is due to the rising prevalence of infectious and chronic diseases and the hospital adoption of point-of-care testing.
Competitive Landscape and Molecular Point of Care Testing (Using NAAT) Market Share Analysis
Middle East molecular point of care testing (using NAAT) market competitive landscape provides details about the competitor. Components included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Middle East presence, production sites and facilities, company strengths and weaknesses, product launch, regulatory guidelines, brand analysis, product approvals, product payload, application dominance, technology lifeline curve. The above data points provided are only related to the companies' focus pertaining to the middle east molecular point of care testing (using NAAT) market.
The major companies providing molecular point of care testing (using NAAT) products in the Middle East molecular point of care testing (using NAAT) Market are
· SD Biosensor, Inc.,
· Abbott, F.Hoffmann-La Roche Ltd.,
· Thermo Fisher Scientific Inc,
· Meridian Bioscience, BD,
· Biomérieux Sa,
· Qiagen, Quidel Corporation,
· Bio-Rad Laboratories, Inc.,
· GenMark Diagnostics,
· Seegene Inc.,
· and Grifols S.A. among others.
Browse Related Reports @
Europe Commercial Dishwashers Market
U.S. Private Label Food and Beverages Market
Europe Point-Of-Care-Testing (POCT) Market
Thailand Point-of-Care Testing (POCT) Market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best Market opportunities and foster efficient information for your business to thrive in the Market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek